, Volume 43, Issue 2, pp 351–359 | Cite as

C-reactive protein concentration as a significant correlate for metabolic syndrome: a Chinese population-based study

  • Tsan Yang
  • Chi-Hong Chu
  • Po-Chien Hsieh
  • Chih-Hsung Hsu
  • Yu-Ching Chou
  • Shih-Hsien Yang
  • Chyi-Huey Bai
  • San-Lin You
  • Lee-Ching Hwang
  • Tieh-Chi Chung
  • Chien-An Sun
Original Article


Increasing evidence suggests that chronic, low-grade inflammation may be a common soil involving the pathogenesis of metabolic syndrome (MetS) and cardiovascular disease. We examined the association between C-reactive protein (CRP) concentration, an extensively studied biomarker of low-grade inflammation, and the MetS in a representative sample of Chinese adults in Taiwan. We performed a cross-sectional analysis of data from 4234 subjects [mean (±SD) age, 47.1 (±18.2) years; 46.4 % males] who participated in a population-based survey on prevalences of hypertension, hyperglycemia, and hyperlipidemia in Taiwan. CRP levels were measured by the immunoturbidimetric CRP-latex high-sensitivity assay. The MetS was defined by an unified criteria set by several major organizations. Odds ratios (ORs) and 95 % confidence intervals (CIs) were calculated with logistic regression model. Overall, there were 938 subjects with MetS among 4,234 participants, resulting in a prevalence rate of 22.1 %. A significantly progressive increase in the prevalence of MetS across quartiles of CRP was observed (p for trend <0.001). Participants in the second, third, and upper quartiles of CRP had significantly higher risk of having MetS when compared with those in the lowest quartile [adjusted ORs (95 % CIs) were 2.18 (1.62–2.94), 4.39 (3.31–5.81), and 7.11 (5.39–9.38), respectively; p for trend <0.001]. Furthermore, there was a strong stepwise increase in CRP levels as the number of components of the MetS increased. The prevalence of MetS showed a graded increase according to CRP concentrations. The possible utility of CRP concentration as a marker for MetS risk awaits further evaluation in prospective studies.


Chinese C-reactive protein Cross-sectional study Inflammation Metabolic syndrome 


  1. 1.
    K.G.M.M. Alberti, R.H. Eckel, S.M. Grundy, P.Z. Zimmet, J.I. Cleeman, K.A. Donato, J.C. Fruchart, W.P.T. James, C.M. Loria, S.C. Smith, Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120, 1640–1645 (2009)PubMedCrossRefGoogle Scholar
  2. 2.
    B. Isomaa, P. Almgren, T. Tuomi, B. Forsen, K. Lahti, M. Nissen, M.R. Taskinen, L. Groop, Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24, 683–689 (2001)PubMedCrossRefGoogle Scholar
  3. 3.
    C.M. Ballantyne, R.C. Hoogeveen, A.M. McNeill, G. Heiss, M.I. Schmidt, B.B. Duncan, J.S. Pankow, Metabolic syndrome risk for cardiovascular disease and diabetes in the ARIC study. Int. J. Obes. 32, S21–S24 (2008)CrossRefGoogle Scholar
  4. 4.
    S.M. Haffner, The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am. J. Cardiol. 97(suppl), 3A–11A (2006)PubMedCrossRefGoogle Scholar
  5. 5.
    M.K. Rutter, J.B. Meigs, L.M. Sullivan, R.B. D’Agostino, P.W.F. Wilson, C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham offspring study. Circulation 110, 380–385 (2004)PubMedCrossRefGoogle Scholar
  6. 6.
    T.S. Han, N. Sattar, K. Williams, C. Gonzalez-Villalpando, M.E. Lean, S.M. Haffner, Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City diabetes study. Diabetes Care 25, 2016–2021 (2002)PubMedCrossRefGoogle Scholar
  7. 7.
    S.E. Shoelson, L. Herrero, A. Naaz, Obesity inflammation and insulin resistance. Gastroenterology 132, 2169–2180 (2007)PubMedCrossRefGoogle Scholar
  8. 8.
    P. Deurenberg, M. Deurenberg-Yap, S. Guricci, Asians are different from Caucasians and from each other in their body mass index/body fat percent relationship. Obes. Rev. 3, 141–146 (2002)PubMedCrossRefGoogle Scholar
  9. 9.
    C.J. Chang, C.H. Wu, C.S. Chang, W.J. Yao, Y.C. Yang, J.S. Wu, F.H. Lu, Low body mass index but high percent body fat in Taiwanese subjects: implications of obesity cutoffs. Int. J. Obes. 27, 253–259 (2003)CrossRefGoogle Scholar
  10. 10.
    T. Yang, C.H. Chu, C.H. Bai, S.L. You, Y.C. Chou, W.Y. Chou, K.L. Chien, L.C. Hwang, T.C. Su, C.H. Tseng, C.A. Sun, Uric acid as a risk marker for metabolic syndrome: a Chinese cohort study. Atherosclerosis 220, 525–531 (2012)PubMedCrossRefGoogle Scholar
  11. 11.
    T. Yang T, C.H. Chu, C.H. Bai, S.L. You, Y.C. Chou, L.H. Hwang, K.L. Chien, T.C. Su, C.H. Tseng, C.A. Sun, Uric acid concentration as a risk marker for blood pressure progression and incident hypertension: a Chinese cohort study. Metabolism. doi:10.1016/j.metabol.2012.05.006
  12. 12.
    J.A. Topouchian, M.A. El Assaad, L.V. Orobinskaia, R.N. El Feghali, R.G. Asmar, Validation of two devices for self-measurement of brachial blood pressure according to the International Protocol of the European Society of Hypertension: the SEINEX SE-9400 and the Microlife BP 3AC1-1. Blood Press. Monit. 10, 325–331 (2005)PubMedCrossRefGoogle Scholar
  13. 13.
    W.L. Roberts, L. Moulton, T.C. Law, G. Farrow, M. Cooper-Anderson, J. Savory, N. Rifai, Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications, part 2. Clin. Chem. 47, 418–425 (2001)PubMedGoogle Scholar
  14. 14.
    W.H. Pan, K.M. Flegal, H.Y. Chang, W.T. Yeh, C.J. Yeh, W.C. Lee, Body mass index and obesity-related metabolic disorders in Taiwanese and US whites and blacks: implications for definitions of overweight and obesity for Asians. Am. J. Clin. Nutr. 79, 313–319 (2004)Google Scholar
  15. 15.
    Expert Panel on detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285, 2486–2497 (2001)CrossRefGoogle Scholar
  16. 16.
    L.A. Bazzano, J. He, P. Muntner, S. Vupputuri, P.K. Whelton, Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann. Intern. Med. 138, 891–897 (2003)PubMedGoogle Scholar
  17. 17.
    M.A. Albert, R.J. Glynn, P.M. Ridker, Alcohol consumption and plasma concentration of C-reactive protein. Circulation 157, 443–447 (2003)CrossRefGoogle Scholar
  18. 18.
    A. Festa, R. D’Agostino Jr, G. Howard, L. Mykkanen, R.P. Tracy, S.M. Haffner, Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS). Circulation 102, 42–47 (2000)PubMedCrossRefGoogle Scholar
  19. 19.
    M. Frohlich, A. Imhof, G. Berg, W.L. Hutchinson, M.B. Pepys, H. Boeing, R. Muche, H. Brenner, W. Koenig, Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 23, 1835–1839 (2000)PubMedCrossRefGoogle Scholar
  20. 20.
    N. Nakanishi, T. Shiraishi, M. Wada, C-reactive protein concentration is more strongly related to metabolic syndrome in women than in men: the Minoh study. Circ. J. 69, 386–391 (2005)PubMedCrossRefGoogle Scholar
  21. 21.
    S. Bo, L. Gentile, G. Ciccone, C. Baldi, L. Benini, F. Dusio, C. Lucia, G. Forastiere, C. Nuti, M. Cassader, G. Franco Paqano, The metabolic syndrome and high C-reactive protein: prevalence and differences by sex in a southern European population-based cohort. Diabetes Metab. Res. Rev. 21, 515–524 (2005)PubMedCrossRefGoogle Scholar
  22. 22.
    X. Ye, Z. Yu, H. Li, O.H. Franco, Y. Liu, X. Lin, Distributions of C-reactive protein and its association with metabolic syndrome in middle-aged and older Chinese people. J. Am. Coll. Cardiol. 49, 1798–1805 (2007)PubMedCrossRefGoogle Scholar
  23. 23.
    R. Schwartz, S. Osborne-Lawrence, L. Hahner, L.L. Gibson, A.K. Gormley, W. Vongpatanasin, W. Zhu, R. Ann Word, D. Seetharam, S. Black, D. Samols, C. Mineo, P.W. Shaul, C-reactive protein downregulates endothelial NO synthase and attenuates reendothelialization in vivo in mice. Circ. Res. 100, 1452–1459 (2007)PubMedCrossRefGoogle Scholar
  24. 24.
    H. Teoh, A. Quan, F. Lovren, G. Wang, S. Tirqari, P.E. Szmitko, A.J. Szalai, M.E. Ward, S. Verma, Impaired endothelial function in C-reactive protein overexpressing mice. Atheroslcerosis 201, 318–325 (2008)CrossRefGoogle Scholar
  25. 25.
    W.A. Hsueh, M.J. Quinones, Role of endothelial dysfunction in insulin resistance. Am. J. Cardiol. 92, 10J–17J (2003)PubMedCrossRefGoogle Scholar
  26. 26.
    T. Suzuki, K. Hirata, M.S. Elkind, Z. Jin, T. Rundek, Y. Miyake, B. Boden-Albala, M.R. Di Tullio, R. Sacco, S. Homma, Metabolic syndrome, endothelial dysfunction, and risk of cardiovascular events: the Northern Manhattan Study (NOMAs). Am. Heart J. 156, 405–410 (2008)PubMedCrossRefGoogle Scholar
  27. 27.
    N. Melikian, P. Chowienczyk, P.A. MacCarthy, I.L. Williams, S.B. Wheatcroft, R. Sherwood, C. Gale, A.M. Shah, M.T. Keamey, Determinants of endothelial function in asymptomatic subjects with and without the metabolic syndrome. Atherosclerosis 197, 375–382 (2008)PubMedCrossRefGoogle Scholar
  28. 28.
    J. Cermak, N.S. Key, R.R. Bach, G.M. Vercellotti, C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 82, 513–520 (1993)PubMedGoogle Scholar
  29. 29.
    U. Singh, S. Devaraj, J. Vasquez-Vivar, I. Jialal, C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling. J. Mol. Cell Cardiol. 43, 780–791 (2007)PubMedCrossRefGoogle Scholar
  30. 30.
    E. Ferrannini, S.M. Haffner, B.D. Mitchell, M.P. Stern, Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34, 416–422 (1991)PubMedCrossRefGoogle Scholar
  31. 31.
    G. Hotamisligil, Inflammation and metabolic disorders. Nature 444, 860–867 (2006)PubMedCrossRefGoogle Scholar
  32. 32.
    Y. Xu, Z. Zhao, X. Li, Y. Bi, M. Xu, G. Ning, Relationships between C-reactive protein, white blood cell count, and insulin resistance in a Chinese population. Endocrine 39, 175–181 (2011)PubMedCrossRefGoogle Scholar
  33. 33.
    R. Karnchanasorn, H.Y. Ou, L.M. Chuang, K.C. Chiu, Insulin resistance is not necessarily an essential element of metabolic syndrome. Endocrine (2012). doi:10.1007/s12020-012-9702-3 PubMedGoogle Scholar
  34. 34.
    S.S. Anand, F. Razak, Q. Yi, B. Davis, R. Jacobs, V. Vuksan, E. Lonn, K. Teo, M. McQueen, S. Yusuf, C-reactive protein as a screening test for cardiovascular risk in a multiethnic population. Arterioscler. Thromb. Vasc. Biol. 24, 1509–1515 (2004)PubMedCrossRefGoogle Scholar
  35. 35.
    K.A. Matthews, M.F. Sowers, C.A. Derby, E. Stein, H. Miracle-McMahill, S.L. Crawford, R.C. Pastemark, Ethnic differences in cardiovascular risk factor burden among middle-aged women: study of Women’s Health Across the Nation (SWAN). Am. Heart J. 149, 1066–1073 (2005)PubMedCrossRefGoogle Scholar
  36. 36.
    A.J. MacGregor, J.R. Gallimore, T.D. Spector, M.B. Pepys, Genetic effects on baseline values of C-reactive protein and serum amyloid A protein: a comparison of monozygotic and dizygotic twins. Clin. Chem. 50, 130–134 (2004)PubMedCrossRefGoogle Scholar
  37. 37.
    M.A. Mendall, P. Patel, L. Ballam, D. Strachan, T.C. Northfield, C-reactive protein and its relation to cardiovascular risk factors: a population-based cross-sectional study. Br. Med. J. 312, 1061–1065 (1996)CrossRefGoogle Scholar
  38. 38.
    G.S. Hotamisligil, N.S. Shargill, B.M. Spiegelman, Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259, 87–91 (1993)PubMedCrossRefGoogle Scholar
  39. 39.
    P.A. Kern, S. Ranganathan, C. Li, L. Wood, G. Ranqanathan, Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 280, E745–E751 (2001)PubMedGoogle Scholar
  40. 40.
    H. Baumann, J. Gauldie, Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. Mol. Biol. Med. 7, 147–159 (1990)PubMedGoogle Scholar
  41. 41.
    I.S. Ockene, C.E. Matthews, N. Rifai, P.M. Ridker, G. Reed, E. Stanek, Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin. Chem. 47, 444–450 (2001)PubMedGoogle Scholar
  42. 42.
    H.K.M. Meier-Ewert, P.M. Ridker, N. Rifai, N. Price, D.F. Dinges, J.M. Mullington, Absence of diurnal variation of C-reactive protein levels in healthy human subjects. Clin. Chem. 47, 426–430 (2001)PubMedGoogle Scholar
  43. 43.
    P.M. Ridker, High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 103, 1813–1818 (2001)PubMedCrossRefGoogle Scholar
  44. 44.
    C.H. Tsai, T.C. Li, H.S. Tsay, Factor analysis of modifiable cardiovascular risk factors and prevalence of metabolic syndrome in adult Taiwanese. Endocrine 40, 256–264 (2011)PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Tsan Yang
    • 1
  • Chi-Hong Chu
    • 2
  • Po-Chien Hsieh
    • 3
  • Chih-Hsung Hsu
    • 3
  • Yu-Ching Chou
    • 3
  • Shih-Hsien Yang
    • 4
  • Chyi-Huey Bai
    • 5
  • San-Lin You
    • 6
  • Lee-Ching Hwang
    • 7
  • Tieh-Chi Chung
    • 8
  • Chien-An Sun
    • 9
  1. 1.Department of Health Business AdministrationMeiho UniversityNeipuTaiwan
  2. 2.Department of Surgery, Tri-Service General HospitalNational Defense Medical CenterTaipei CityTaiwan
  3. 3.School of Public HealthNational Defense Medical CenterTaipei CityTaiwan
  4. 4.Graduate Institute of Medical SciencesNational Defense Medical CenterTaipei CityTaiwan
  5. 5.School of Public Health, College of Public Health and NutritionTaipei Medical UniversityTaipei CityTaiwan
  6. 6.Genomics Research CenterAcademia SinicaTaipei CityTaiwan
  7. 7.Mackay Medical CollegeNew Taipei CityTaiwan
  8. 8.Graduate Institute of Health CareMeiho UniversityPingtung CountyTaiwan
  9. 9.Department of Public Health, College of MedicineFu-Jen Catholic UniversityNew Taipei CityTaiwan, ROC

Personalised recommendations